Apricus Biosciences Updates Strategic Corporate Objectives

Go back to Apricus Biosciences Updates Strategic Corporate Objectives

Apricus Biosciences (APRI) Gains Early on Refocused Strategy

April 6, 2016 7:13 AM EDT

Apricus Biosciences (Nasdaq: APRI) shares are notably higher in early trading Wednesday after the company announced an update to its strategic objectives. The company said it plans to "prioritize Vitaros commercial and regulatory activities and to deprioritize all other pipeline programs."

Shares of Apricus are indicated over 17 percent higher.

... More